NZ703345A - Compositions and methods for reducing frequency and/or severity of headache - Google Patents

Compositions and methods for reducing frequency and/or severity of headache

Info

Publication number
NZ703345A
NZ703345A NZ703345A NZ70334513A NZ703345A NZ 703345 A NZ703345 A NZ 703345A NZ 703345 A NZ703345 A NZ 703345A NZ 70334513 A NZ70334513 A NZ 70334513A NZ 703345 A NZ703345 A NZ 703345A
Authority
NZ
New Zealand
Prior art keywords
headache
severity
subject
frequency
reducing
Prior art date
Application number
NZ703345A
Other languages
English (en)
Inventor
Ralph Bright
Pelin Bright
Bruce Hansen
Wayne Thomas
Original Assignee
Rusty Property Holdings Pty Ltd
Amberdale Entpr Pty Ltd
Tavid Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012902720A external-priority patent/AU2012902720A0/en
Application filed by Rusty Property Holdings Pty Ltd, Amberdale Entpr Pty Ltd, Tavid Pty Ltd filed Critical Rusty Property Holdings Pty Ltd
Publication of NZ703345A publication Critical patent/NZ703345A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vascular Medicine (AREA)
NZ703345A 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache NZ703345A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012902720A AU2012902720A0 (en) 2012-06-26 Compositions and methods for reducing frequency and/or severity of headache
PCT/AU2013/000684 WO2014000029A1 (en) 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache

Publications (1)

Publication Number Publication Date
NZ703345A true NZ703345A (en) 2017-03-31

Family

ID=49781943

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ703345A NZ703345A (en) 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache

Country Status (9)

Country Link
US (1) US10206956B2 (enExample)
EP (1) EP2863927A4 (enExample)
JP (1) JP2015521630A (enExample)
KR (1) KR20150091037A (enExample)
CN (1) CN104902909A (enExample)
AU (1) AU2013284338B2 (enExample)
CA (1) CA2877022A1 (enExample)
NZ (1) NZ703345A (enExample)
WO (1) WO2014000029A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2994147A4 (en) * 2013-05-10 2017-03-08 Cell-Innovations IP Pty Ltd Compositions and methods for the treatment of tinnitus
KR20160027127A (ko) * 2013-07-01 2016-03-09 아미트 프라카시 고빌 연조직 임플란트
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
JP6829225B2 (ja) * 2018-06-13 2021-02-10 株式会社 バイオミメティクスシンパシーズ モノアミン産生増加剤としての間葉系幹細胞を含む医薬組成物
CN110772535A (zh) * 2018-07-12 2020-02-11 南通大学 多系分化持续应激细胞在制备镇痛药物中的应用
JP6497827B1 (ja) * 2018-07-17 2019-04-10 株式会社 バイオミメティクスシンパシーズ エイコサノイド産生促進剤
WO2020084135A1 (en) 2018-10-26 2020-04-30 Stemselect Method and apparatus for mesenchymal stem cells isolation and purification
WO2022104069A1 (en) * 2020-11-13 2022-05-19 Advanced Therapeutic Lab, Inc. Therapeutic methods and compositions utilizing stromal vascular fraction derived from adipose tissue

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2306335C2 (ru) * 1999-03-10 2007-09-20 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стволовые клетки и решетки, полученные из жировой ткани
JP2005533480A (ja) * 2001-11-09 2005-11-10 アーテセル・サイエンシズ・インコーポレーテツド 脂肪組織由来間質細胞の膵内分泌分化およびその使用
ES2375565T3 (es) * 2003-08-07 2012-03-02 Healor Ltd. Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas.
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
FR2901136B1 (fr) * 2006-05-18 2010-10-01 Centre Nat Rech Scient Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral
JP2010037292A (ja) 2008-08-06 2010-02-18 Univ Of Tokyo 脂肪由来幹細胞と塩基性線維芽細胞増殖因子を組み合わせた線維性病変の治療法
NZ591292A (en) * 2008-08-20 2012-10-26 Anthrogenesis Corp Improved cell composition and methods of making the same
CA2734237C (en) * 2008-08-20 2019-07-02 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
WO2010071862A1 (en) * 2008-12-19 2010-06-24 Ethicon, Incorporated Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
AU2009100401A4 (en) * 2009-04-30 2009-06-04 Gl Holdings Inc Bv Method of extracting and activating adipose-derived stem cells
EP2424463B1 (en) * 2009-05-01 2016-12-28 Bimini Technologies LLC Systems, methods and compositions for optimizing tissue and cell enriched grafts
JP2011010581A (ja) 2009-06-30 2011-01-20 Kaneka Corp 幹細胞分離材、幹細胞分離フィルター、及び該分離材または該分離フィルターを用いた幹細胞分離方法、幹細胞回収方法
JP5905446B2 (ja) 2010-03-24 2016-04-20 ライフネット ヘルス Ｂｍｐ−４ペプチドおよび使用方法
WO2011138786A2 (en) * 2010-05-06 2011-11-10 Stem Cell Medicine Ltd. Stem cell bank for personalized medicine
KR20200116546A (ko) * 2010-12-17 2020-10-12 안트로제네시스 코포레이션 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
WO2012091911A1 (en) * 2010-12-27 2012-07-05 Intellicell Biosciences, Inc. Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
KR101903339B1 (ko) * 2011-03-22 2018-10-01 플루리스템 리미티드 방사선 또는 화학적 손상을 치료하는 방법
DK2714059T3 (en) * 2011-06-01 2019-01-21 Celularity Inc TREATMENT OF PAIN WHEN USING PLACENT STAM CELLS
JP5598864B2 (ja) * 2011-12-05 2014-10-01 北海道公立大学法人 札幌医科大学 細胞増殖方法ならびに組織の修復および再生のための医薬

Also Published As

Publication number Publication date
US10206956B2 (en) 2019-02-19
JP2015521630A (ja) 2015-07-30
EP2863927A1 (en) 2015-04-29
AU2013284338A1 (en) 2015-01-22
EP2863927A4 (en) 2015-12-02
KR20150091037A (ko) 2015-08-07
CN104902909A (zh) 2015-09-09
AU2013284338B2 (en) 2018-03-01
US20150174172A1 (en) 2015-06-25
WO2014000029A1 (en) 2014-01-03
CA2877022A1 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
MY178152A (en) Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use
WO2013070881A8 (en) Method for elimination of space through tissue approximation
MX390739B (es) Composicion de hueso comprimido y metodo para usar la misma.
MX381456B (es) Regulador de ph de transduccion.
SG10201901713RA (en) Extracellular matrix compositions
WO2014058804A3 (en) Micronized compositions composed of bone grafts and methods of making and using the same
HK1212239A1 (en) Methods for prevention and treatment of preeclampsia
IN2015DN03322A (enExample)
HK1218139A1 (zh) 去分化的重新編程細胞所衍生的細胞組合物
PH12015502289A1 (en) Creamer composition comprising plant protein microparticles
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
WO2012168410A3 (en) Methods for treating lignocellulosic material
PH12015502405A1 (en) Methods and compositions for wound healing
BR112016030758B8 (pt) Uso de células estromais multipotentes derivadas de tecido adiposo mesenquimal
IL274538B (en) A preparation containing mesenchymal stem cells for tissue regeneration and a method for its production
SMT201900426T1 (it) Sigillante di tessuto in cui collagene e fibrina sono miscelati e metodo per preparare lo stesso
MX2016016756A (es) Terapia con células madre en patologías endometriales.
MX358132B (es) Solucion de trombina y metodos de uso de esta.
MX362175B (es) Composiciones de proteina del gen 3 de bacteriofago y sus usos como agentes de union amiloides.
HK1202375A1 (en) Skin lightening compositions
EP2863927A4 (en) COMPOSITIONS AND METHODS FOR REDUCING THE FREQUENCY AND / OR INTENSITY OF THE CEPHALA
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
WO2012119103A3 (en) Compositions and methods for mobilization of stem cells
PH12012501548A1 (en) Compositions comprising sugar-cysteine products
SG10202010615QA (en) Method for promoting and improving properties of adipose tissue, tissue and cells obtained by said method